FR2309212A1 - Pastille implantable sous la peau et comprenant du propionate de dromostanolone - Google Patents

Pastille implantable sous la peau et comprenant du propionate de dromostanolone

Info

Publication number
FR2309212A1
FR2309212A1 FR7612471A FR7612471A FR2309212A1 FR 2309212 A1 FR2309212 A1 FR 2309212A1 FR 7612471 A FR7612471 A FR 7612471A FR 7612471 A FR7612471 A FR 7612471A FR 2309212 A1 FR2309212 A1 FR 2309212A1
Authority
FR
France
Prior art keywords
tablet
skin
dromostanolone propionate
implantable under
implantable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7612471A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of FR2309212A1 publication Critical patent/FR2309212A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036—Silicones; Polysiloxanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7612471A 1975-04-28 1976-04-27 Pastille implantable sous la peau et comprenant du propionate de dromostanolone Withdrawn FR2309212A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/572,691 US3991750A (en) 1975-04-28 1975-04-28 Dromostanolone propionate implant pellet useful for producing weight gains in animals and suppressing estrus in female animals

Publications (1)

Publication Number Publication Date
FR2309212A1 true FR2309212A1 (fr) 1976-11-26

Family

ID=24288938

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7612471A Withdrawn FR2309212A1 (fr) 1975-04-28 1976-04-27 Pastille implantable sous la peau et comprenant du propionate de dromostanolone

Country Status (6)

Country Link
US (1) US3991750A (fr)
JP (1) JPS51133410A (fr)
BE (1) BE841166A (fr)
DE (1) DE2618129A1 (fr)
FR (1) FR2309212A1 (fr)
NL (1) NL7604459A (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0013949A2 (fr) * 1979-01-23 1980-08-06 Hoechst Aktiengesellschaft Corps de dépôt à base de caoutchouc de silicone et procédé pour sa préparation
FR2653337A1 (fr) * 1989-10-23 1991-04-26 Dow Corning Sa Element a liberation prolongee et procede pour le fabriquer.
EP0824020A1 (fr) * 1996-08-14 1998-02-18 Dow Corning France S.A. Procédé de fabrication d'un dispositif à libération contrÔlée

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1551620A (en) * 1976-12-13 1979-08-30 Ici Ltd Delivery means for biologically active agents
US4209014A (en) * 1977-12-12 1980-06-24 Canadian Patents And Development Limited Dispensing device for medicaments
US4326523A (en) * 1980-08-25 1982-04-27 International Minerals & Chemical Corp. Method of supplying micronutrients to animals
US4326524A (en) * 1980-09-30 1982-04-27 Minnesota Mining And Manufacturing Company Solid dose ballistic projectile
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
AU571922B2 (en) * 1984-01-26 1988-04-28 Schering Agrochemicals Limited Veterinary implants comprising melatonin and derivatives thereof
NZ207341A (en) * 1984-03-01 1988-02-29 Harvey Alex Ind Ltd Device containing chemical impregnants for insertion into a body cavity of an animal
AU601736B2 (en) * 1986-05-23 1990-09-20 Sanofi Sante Nutrition Animale Sa Coated veterinary implants
KR20060066753A (ko) 1997-10-22 2006-06-16 젠스 포니카우 진균류에 의한 점막염을 국소 치료하기 위한 항진균제의용도
US6251418B1 (en) * 1997-12-18 2001-06-26 C.R. Bard, Inc. Systems and methods for local delivery of an agent
US6197324B1 (en) 1997-12-18 2001-03-06 C. R. Bard, Inc. System and methods for local delivery of an agent
CA2316949A1 (fr) 1997-12-29 1999-07-08 Alza Corporation Dispositif d'implantation sous-cutanee
US6028057A (en) * 1998-02-19 2000-02-22 Thorn Bioscience, Llc Regulation of estrus and ovulation in gilts
US6197815B1 (en) 1998-03-18 2001-03-06 J.H. Biotech, Inc. Amino acid chelates to reduce still births and increase birth weight in non-human animals
US6689121B1 (en) 1998-09-24 2004-02-10 C. R. Bard, Inc. Systems and methods for treating ischemia
US6248112B1 (en) 1998-09-30 2001-06-19 C. R. Bard, Inc. Implant delivery system
US6251079B1 (en) 1998-09-30 2001-06-26 C. R. Bard, Inc. Transthoracic drug delivery device
US6432126B1 (en) 1998-09-30 2002-08-13 C.R. Bard, Inc. Flexible vascular inducing implants
US6458092B1 (en) 1998-09-30 2002-10-01 C. R. Bard, Inc. Vascular inducing implants
US6692520B1 (en) 1998-12-15 2004-02-17 C. R. Bard, Inc. Systems and methods for imbedded intramuscular implants
US6986784B1 (en) 1999-05-14 2006-01-17 C. R. Bard, Inc. Implant anchor systems
US6855160B1 (en) 1999-08-04 2005-02-15 C. R. Bard, Inc. Implant and agent delivery device
US7232421B1 (en) 2000-05-12 2007-06-19 C. R. Bard, Inc. Agent delivery systems
US7204847B1 (en) 2000-07-28 2007-04-17 C. R. Bard, Inc. Implant anchor systems
US20030165614A1 (en) * 2002-03-01 2003-09-04 Henrik Hansen Coating a medical implant using a pan coater
AU2003297534A1 (en) * 2002-12-24 2004-07-22 Ovion, Inc. Contraceptive device and delivery system
US7572298B2 (en) * 2003-03-28 2009-08-11 Ethicon, Inc. Implantable medical devices and methods for making same
ES2555681T3 (es) 2003-10-03 2016-01-07 Thorn Bioscience, Llc Procedimiento para la sincronización de la ovulación para la fecundación programada sin detección del celo
US20070197435A1 (en) * 2006-02-17 2007-08-23 Webel Stephen K Process for the synchronization of ovulation for timed breeding without heat detection
US8235047B2 (en) 2006-03-30 2012-08-07 Conceptus, Inc. Methods and devices for deployment into a lumen
ES2581765T3 (es) 2006-08-24 2016-09-07 University Of Tennessee Research Foundation Acilanilidas sustituidas y métodos de uso de las mismas
BR122013009981B1 (pt) 2009-04-23 2020-02-11 United-Ah Ii, Llc Composição para sincronizar o tempo de inseminação
US10314807B2 (en) 2012-07-13 2019-06-11 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US10987334B2 (en) 2012-07-13 2021-04-27 University Of Tennessee Research Foundation Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9969683B2 (en) 2012-07-13 2018-05-15 Gtx, Inc. Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
US9604916B2 (en) 2012-07-13 2017-03-28 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
AU2013352054A1 (en) 2012-11-28 2015-06-04 United-Ah Ii, Llc Method for synchronizing time of insemination in gilts
US9980850B2 (en) * 2016-09-29 2018-05-29 Gesea Biosciences, Inc. Bioerodible contraceptive implant and methods of use thereof
CN113423391A (zh) 2018-11-29 2021-09-21 因斯格纳公司 作为不育剂的苯甲酸雌二醇
US20200171048A1 (en) * 2018-11-29 2020-06-04 lnsigna lnc. Prevention of boar taint and aggression

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3118915A (en) * 1959-02-24 1964-01-21 Syntex Corp 2alpha-lower alkyl dihydro testosterone and derivatives thereof
US3608549A (en) * 1970-01-15 1971-09-28 Merrill Edward Wilson Method of administering drugs and capsule therefor
US3857932A (en) * 1970-09-09 1974-12-31 F Gould Dry hydrophilic acrylate or methacrylate polymer prolonged release drug implants
US3710795A (en) * 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US3870791A (en) * 1972-04-24 1975-03-11 Heskel M Haddad Solid state ophthalmic medication delivery method
US3867519A (en) * 1972-04-27 1975-02-18 Alza Corp Bioerodible drug delivery device

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0013949A2 (fr) * 1979-01-23 1980-08-06 Hoechst Aktiengesellschaft Corps de dépôt à base de caoutchouc de silicone et procédé pour sa préparation
EP0013949A3 (en) * 1979-01-23 1981-07-22 Hoechst Aktiengesellschaft Depot form based on silicon rubber and method for its preparation
FR2653337A1 (fr) * 1989-10-23 1991-04-26 Dow Corning Sa Element a liberation prolongee et procede pour le fabriquer.
EP0425154A1 (fr) * 1989-10-23 1991-05-02 Dow Corning France S.A. Eléments à libération prolongée
EP0824020A1 (fr) * 1996-08-14 1998-02-18 Dow Corning France S.A. Procédé de fabrication d'un dispositif à libération contrÔlée
FR2752380A1 (fr) * 1996-08-14 1998-02-20 Dow Corning Sa Procede de fabrication d'un dispositif a liberation controlee

Also Published As

Publication number Publication date
US3991750A (en) 1976-11-16
BE841166A (fr) 1976-10-27
DE2618129A1 (de) 1976-11-11
JPS51133410A (en) 1976-11-19
NL7604459A (nl) 1976-11-01

Similar Documents

Publication Publication Date Title
BE841166A (fr) Pastille implantable sous la peau et comprenant du propionate de dromostanolone
FR2277573A1 (fr) Appareil de prevention contre l'arythmie cardiaque
AT371996B (de) Kosmetisches behandlungsverfahren
NL188078C (nl) Farmaceutisch preparaat voor de behandeling van hartarrhytmieen en myocardiale aandoeningen.
DK477976A (da) Hudbehandlingsapparat
NL7605187A (nl) Bloeddrukmeter.
IT1109052B (it) Procedimento per la preparazione del polivinil butirrale e prodotto cosi ottenuto
AU1285476A (en) Human heart valve
SE7700815L (sv) Hudbehandlingskomposition
NL7614431A (nl) Werkwijze voor de bereiding van benzyl en aryl- esters van n-fosfonomethylglycinen, van herbicide preparaten en de toepassing daarvan.
YU131376A (en) Medical fluid-container
BE871584A (fr) Preparations pharmaceutiques
IT1074161B (it) Apparecchio elettroterapeutico
JPS5239997A (en) Blood processor
NL7612200A (nl) Retinezuurderivaat alsmede farmaceutisch preparaat voor de behandeling van acne.
NZ185279A (en) Medical treatment utilising pseudomonic acid derivative
NO783971L (no) Hudpleiepreparat.
SE7609100L (sv) Hudbehandlingskomposition
NL7606344A (nl) Zonnebrandmiddel voor de menselijke huid.
FI781330A (fi) Foerbaettrad begraensare foer medelstroemmaengden av en straole
DK149876A (da) Forbedret forud farvet objektberer til blodundersogelse
NL7611088A (nl) N-acetylmuramyl-d-alanyl-d-isoglutamine en werk- wijze voor de bereiding en toepassing ervan.
SE7704309L (sv) Bestralningsapparat for behandling av hudsjukdomar
AU1306576A (en) Pharmaceutical formulation
DK2776A (da) Oplosning til hudbehandling samt dermed fremstillet vadble

Legal Events

Date Code Title Description
ST Notification of lapse